Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Read More…
Industry, Sector and Symbol
Industry Drug stores & proprietary stores
Sub-IndustryHealth Care Services
SectorMedical
Phone314-996-0900
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$100.06 billion
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableOptionable
Express Scripts (NASDAQ:ESRX) Frequently Asked Questions
What is Express Scripts' stock symbol?
Express Scripts trades on the NASDAQ under the ticker symbol "ESRX."
How will Express Scripts' stock buyback program work?
Express Scripts declared that its board has authorized a stock repurchase program on Wednesday, December 20th 2017, which allows the company to buyback 45,000,000 shares, according to EventVestor. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Shares buyback programs are often a sign that the company's board believes its shares are undervalued.
How were Express Scripts' earnings last quarter?
Express Scripts Holding Co (NASDAQ:ESRX) issued its quarterly earnings data on Wednesday, October, 31st. The company reported $2.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.42 by $0.01. The firm had revenue of $25.56 billion for the quarter, compared to analysts' expectations of $25.11 billion. Express Scripts had a return on equity of 25.43% and a net margin of 4.83%. The company's revenue for the quarter was up 3.6% on a year-over-year basis. During the same period last year, the firm earned $2.51 EPS. View Express Scripts' Earnings History.
What price target have analysts set for ESRX?
8 analysts have issued 1 year price objectives for Express Scripts' stock. Their forecasts range from $88.00 to $101.00. On average, they expect Express Scripts' stock price to reach $96.0833 in the next twelve months. This suggests a possible upside of 4.1% from the stock's current price. View Analyst Price Targets for Express Scripts.
What is the consensus analysts' recommendation for Express Scripts?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Express Scripts in the last year. There are currently 6 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Express Scripts.
Has Express Scripts been receiving favorable news coverage?
Media headlines about ESRX stock have been trending positive recently, InfoTrie reports. The research firm identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Express Scripts earned a media sentiment score of 2.5 on InfoTrie's scale. They also gave news articles about the company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the stock's share price in the next several days. View News Stories for Express Scripts.
Who are some of Express Scripts' key competitors?
What other stocks do shareholders of Express Scripts own?
Who are Express Scripts' key executives?
Express Scripts' management team includes the folowing people:
- Mr. Timothy C. Wentworth, CEO, Pres & Director (Age 58)
- Mr. James M. Havel, Exec. VP & CFO (Age 63)
- Mr. David A. Queller, Sr. VP of Sales & Account Management (Age 49)
- Ms. Christine Houston, Exec. VP of Strategic Integrations (Age 55)
- Mr. Everett Neville, Exec. VP of Strategy, Supply Chain & Specialty (Age 53)
Who are Express Scripts' major shareholders?
Express Scripts' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include HBK Sorce Advisory LLC (0.00%), HBK Sorce Advisory LLC (0.00%) and Private Capital Group LLC (0.00%). Company insiders that own Express Scripts stock include Christine Houston, Everett Neville, Glen D Stettin, Mahon Thomas P Mac, Phyllis S Anderson, Timothy C Wentworth and Woodrow A Myers Jr. View Institutional Ownership Trends for Express Scripts.
Which major investors are buying Express Scripts stock?
How do I buy shares of Express Scripts?
Shares of ESRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Express Scripts' stock price today?
One share of ESRX stock can currently be purchased for approximately $92.33.
How big of a company is Express Scripts?
Express Scripts has a market capitalization of $52.06 billion and generates $100.06 billion in revenue each year. The company earns $4.52 billion in net income (profit) each year or $7.10 on an earnings per share basis. View Additional Information About Express Scripts.
What is Express Scripts' official website?
How can I contact Express Scripts?
Express Scripts' mailing address is ONE EXPRESS WAY, SAINT LOUIS MO, 63121. The company can be reached via phone at 314-996-0900 or via email at [email protected]
MarketBeat Community Rating for Express Scripts (NASDAQ ESRX)
MarketBeat's community ratings are surveys of what our community members think about Express Scripts and other stocks. Vote "Outperform" if you believe ESRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ESRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
